As preclinical studies have shown, JAK/STAT signaling is highly complex, and although, on balance, constitutive activation tends to promote tumor proliferation, angiogenesis, and immune escape, targeting upstream or downstream effectors is not always predictable. Here, SOAT1 is linked to neoplasm.